Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets disti…
Biotechnology
US, Brisbane [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Annexon, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAnnexon, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Annexon, Inc..
If you want to see a demo, head over to the financial segments of AAPL